Company intelligence / Profile preview

Colotech A

Clermont-Ferrand, France

Ownership: Private
Development stage: Other

Overview

Colotech is a French biotechnology company focused on developing innovative diagnostic solutions for the early detection and management of colorectal cancer. The company leverages proprietary biomarker technology to create non-invasive tests aimed at improving screening compliance and patient outcomes. Their primary focus is on identifying high-risk individuals and monitoring disease progression through advanced molecular analysis. Colotech aims to integrate its diagnostic tools into standard clinical workflows to reduce the global burden of colorectal cancer.

Therapeutic areas: Oncology
Modalities: Diagnostic testBiomarker-based assay
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Colotech A.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colotech A.

Explore the full profile